mometasoni-17 furoas 0.5 mg ut mometasoni-17 furoas monohydricus 0.51731 mg, cellulosum microcristallinum et carmellosum natricum, glycerolum, acidum citricum monohydricum, natrii citras dihydricus, polysorbatum 80, benzalkonii chloridum 0.2 mg, aqua ad iniectabile, ad suspensionem pro 1 g corresp., mometasoni-17 furoas 50 µg pro dosi, doses pro vase 140.
Packungsbestandteile
Nasal spray
Active Agent
Dose
Mometasone 17 Furoate
0.5 mg/g
BAG: Active Agent
Dose
Mometasone 17 Furoate
0.05 mg
Inactive agents
Dose
Citric Acid Monohydrate
Benzalkonium Chloride
0.2 mg/g
Carmellose Sodium
Cellulosum Microcristallinum
Glycerol
Natrii Citras Dihydricus
Polysorbatum 80
Source
Data was imported : 05.08.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
